19th Annual Harold "Jobe" Bernard Stroke & Neurosciences Symposium
Published: Wednesday, October 5, 2016 2:07 pm
7:00 AM - 5:00 PM
Registration Deadline: Friday, Oct. 21
Fees vary depending on single day or 2-day registration. For specific information on cost, click here.
Who Should Attend
Neurologists, general physicians, nurses, physical therapists, occupational therapists, occupational therapists, speech/language therapists and emergency medical technologists will all benefit from this 2-day event.
After participating in this CME activity, participants should be able to describe and discuss:
1. Criteria for referring patients for interventional stroke treatment
2. Secondary stroke prevention strategies and be able to implement them
3. Approaches to using tele-neurology to manage stroke patients
Statement of Educational Need
Strategies for acute stroke management have changed considerably in the past two years, including two new devices for removing clots, both of which have shown superior efficacy to earlier devices. There were 5 new studies on interventional management of stroke in 2015. Other areas of new development include new anti-coagulation drugs and usefulness of cardiac monitoring. New evidence has emerged regarding anti-platelet therapy of stroke and levels of blood pressure control. Finally, new rehabilitation techniques and devices are emerging. Physicians do not always have information about these new developments and guidance on how to incorporate them into their practices in order to provide the best care for their patients.
CME Credit Designation
Vanderbilt University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Vanderbilt University School of Medicine designates this live activity for a maximum of 15.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
It is the policy of Vanderbilt University School of Medicine to require disclosure of financial relationships from individuals in a position to control the content of a CME activity; to identify and resolve conflicts of interest related to those relationships; and to make disclosure information available to the audience prior to the CME activity. Presenters are required to disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentations.
For Details, Agenda or to Register: